Copyright
©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Jul 21, 2011; 17(27): 3235-3241
Published online Jul 21, 2011. doi: 10.3748/wjg.v17.i27.3235
Published online Jul 21, 2011. doi: 10.3748/wjg.v17.i27.3235
Influence of irritable bowel syndrome on treatment outcome in gastroesophageal reflux disease
Hubert Mönnikes, Department of Medicine, Martin-Luther Hospital, Academic Teaching Hospital of Charité, Universitätsmedizin, 14193 Berlin, Germany
Robert C Heading, Edinburgh, EH10 7AR, Scotland, United Kingdom
Holger Schmitt, Nycomed GmbH, 78467 Constance, Germany
Hubert Doerfler, Nycomed International Management GmbH, 8152 Zurich, Switzerland
Author contributions: Mönnikes H, Heading RC, Schmitt H and Doerfler H were all involved in the study concept and design, analysis and interpretation of data, and the critical revision of the manuscript for important intellectual content; all provided approval of the final manuscript. Additionally, Mönnikes H took a lead role in drafting of the manuscript. Schmitt H and Doerfler H provided administrative, technical, and material support, and were responsible for study supervision.
Supported by Nycomed GmbH
Correspondence to: Hubert Mönnikes, MD, PhD, Department of Medicine, Martin-Luther Hospital, Academic Teaching Hospital of Charité, 14193 Berlin, Germany. moennikes@web.de
Telephone: +49-30-89553100 Fax: +49-30-89554554
Received: November 22, 2010
Revised: February 12, 2011
Accepted: February 19, 2011
Published online: July 21, 2011
Revised: February 12, 2011
Accepted: February 19, 2011
Published online: July 21, 2011
Core Tip